Related Experiment Video
Updated: May 5, 2026
05:06
Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
15.2K
New paradigm for tumor theranostic methodology using bacteria-based microrobot
Sung Jun Park1, Seung-Hwan Park, Sunghoon Cho
1School of Mechanical Systems Engineering, Chonnam National University.
Scientific Reports
|December 3, 2013
Summary
We developed bacteria-based microrobots (bacteriobots) for targeted cancer theranostics. These bacteriobots demonstrate effective tumor-homing capabilities and potential for solid tumor treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Solid tumors present significant challenges for conventional therapies.
- Targeted drug delivery systems are crucial for improving treatment efficacy and reducing side effects.
Purpose of the Study:
- To develop a novel bacteria-based microrobot (bacteriobot) for theranostic applications against solid tumors.
- To evaluate the chemotactic response and tumor-targeting ability of the developed bacteriobots.
Main Methods:
- Bacteria were attached to Cy5.5-coated polystyrene microbeads via biotin-streptavidin interaction.
- Chemotactic migration of bacteriobots towards tumor cell lysates/spheroids was assessed in a microfluidic chamber.
- In vitro and in vivo studies were conducted using CT-26 tumor models.
Main Results:
- Bacteriobots exhibited enhanced migration velocity towards tumor cell components compared to normal cells.
- In vivo studies showed Cy5.5 signal detection at the tumor site after bacteriobot injection.
- In vitro and in vivo tests confirmed chemotactic motility and tumor targeting ability.
Conclusions:
- The developed bacteriobots demonstrate promising chemotactic motility and tumor-targeting capabilities.
- This bacteria-based microrobot paradigm offers a novel theranostic methodology for solid tumor treatment.
- Bacteria acting as microactuators and microsensors represent a new frontier in cancer theranostics.
